Cyanosis other imaging findings

Jump to navigation Jump to search

Cyanosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cyanosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cyanosis other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cyanosis other imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cyanosis other imaging findings

CDC on Cyanosis other imaging findings

Cyanosis other imaging findings in the news

Blogs on Cyanosis other imaging findings

Directions to Hospitals Treating Cyanosis

Risk calculators and risk factors for Cyanosis other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Amandeep Singh M.D.[3]

Overview

Cardiac catheterization is an invasive study for the anatomic and physiological assessment of patients with cyanotic congenital heart disease

Cardiac catheterization

Cardiac catheterization is gold standard for the anatomic and physiological assessment of patients with cyanotic congenital heart disease when determination of the anatomy of congenital heart disease is inadequate by noninvasive imagings.[1]

Cardiac Catheterization

Recommendations for catheterization in congenital heart disease
(Class I, Level of Evidence A):

❑ Obtaining hemodynamic and anatomic data at the time of intervention

(Class I, Level of Evidence B) :

❑ Assessment of pulmonary resistance and reversibility of pulmonary hypertension in patients with CHD or primary pulmonary hypertension for surgical procedure or medical decisions
❑ Assessment of complex pulmonary atresia for determination of lung segmental pulmonary vascular supply, especially when noninvasive imaging are inadequate
❑ Determination of coronary circulation in pulmonary atresia with intact septum
❑ Follow-up of graft vasculopathy after cardiac transplantation

(Class I , Level of Evidence C)

❑ Assessment of patient before cardiac transplantation

(Class 2a, Level of Evidence B)

❑ Determination of pulmonary pressure/resistance and transpulmonary gradient in palliated single-ventricle patients before a staged Fontan procedure
❑ Assessment of cardiomyopathy or myocarditis
❑ Assessment of suspected congenital coronary artery anomalies

(Class 2a, Level of Evidence C)

❑ In any CHD patient in whom complete diagnosis and information cannot be obtained by noninvasive testing
❑ Assessment of anatomy and hemodynamics in postoperative cardiac patients when the early postoperative course is unexpectedly complicated and noninvasive imaging techniques ( cardiac MRA, cardiac CT angiography) fail to reach the diagnosis

References

  1. Feltes, Timothy F.; Bacha, Emile; Beekman, Robert H.; Cheatham, John P.; Feinstein, Jeffrey A.; Gomes, Antoinette S.; Hijazi, Ziyad M.; Ing, Frank F.; de Moor, Michael; Morrow, W. Robert; Mullins, Charles E.; Taubert, Kathryn A.; Zahn, Evan M. (2011). "Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease". Circulation. 123 (22): 2607–2652. doi:10.1161/CIR.0b013e31821b1f10. ISSN 0009-7322.

Template:WH Template:WS